Viewing Study NCT02000050


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-28 @ 11:33 AM
Study NCT ID: NCT02000050
Status: COMPLETED
Last Update Posted: 2025-01-30
First Post: 2013-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module